Showing 1 posts of 1 posts found.
India is set to reduce exports of active pharmaceutical ingredients (APIs) until further notice, due to fears of internal drug …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement